← Back to Search

Device

transcranial direct current stimulation (tDCS) for Epilepsy

Phase < 1
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week of end of the short treatment and within 1 week of end of the long treatment
Awards & highlights

Study Summary

This trial will test whether a brain stimulation technique called tDCS can help reduce seizures and EEG spikes. tDCS will be done at home, and participants will be randomly assigned to either receive real tDCS or a fake (placebo) version.

Eligible Conditions
  • Partial Epilepsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~recorded at time of study entry (baseline) and within 1 week of end of the long treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and recorded at time of study entry (baseline) and within 1 week of end of the long treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in seizures per month
Secondary outcome measures
Change in duration of seizures
Change in severity of seizures
Number of epileptiform EEG spikes

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Long StimulationExperimental Treatment1 Intervention
30 minutes duration of stimulation per day for 30 days
Group II: Short StimulationActive Control1 Intervention
1 minute duration of stimulation per day for 30 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
transcranial direct current stimulation (tDCS)
2014
Completed Phase 1
~800

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,390 Previous Clinical Trials
17,340,697 Total Patients Enrolled
16 Trials studying Epilepsy
1,228 Patients Enrolled for Epilepsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the prerequisites to partake in this trial?

"This trial is seeking approximately 30 participants aged between 18 and 100 years old that have been diagnosed with Gelastic Epilepsy."

Answered by AI

Does this trial offer inclusion to individuals older than twenty years of age?

"Eligibility for this study is limited to those aged between 18 and 100 years old."

Answered by AI

Is this experiment still searching for volunteers?

"The information hosted on clinicaltrials.gov suggest that this trial is not currently accepting new candidates. The study was initially advertised in late May 2021 and the last update was registered at the end of November 2022. Although this research project isn't actively enrolling, there are 245 other medical studies looking for participants presently."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Transcranial Direct Current to Treat Epilepsy at Home
Robert S Fisher 2021. "Transcranial Direct Current to Treat Epilepsy at Home". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04309812.
All > Lgs Foundation
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top